Context:

Colorectal cancer, encompassing colon and rectal cancers, typically begins as noncancerous polyps in the lining of the colon or rectum, with most cases being adenocarcinomas. Risk emerges from a mix of genetics and lifestyle, including obesity, inactivity, red/processed meat intake, smoking, and diabetes, while certain inherited syndromes like Lynch markedly raise lifetime risk. Screening is emphasized as the most effective prevention and early-detection tool, with colonoscopy as a central diagnostic and preventive step. Treatments combine surgery, radiation, and systemic therapies (chemotherapy, targeted therapy, immunotherapy) tailored to stage and molecular features, aiming to remove disease, shrink tumors, or control spread. The piece also underscores disparities in incidence and outcomes, plus lifestyle and surveillance strategies to reduce risk and improve survivorship.

Dive Deeper:

• Most colorectal cancers start as polyps in the colon or rectum; while polyps themselves aren’t cancerous, they can become malignant over time, highlighting the importance of regular screening to detect and remove polyps before they progress.

• About 90% of colon and rectal cancers are adenocarcinomas, with the disease often diagnosed after a screening test identifies something suspicious or a biopsy confirms cancer cells following a procedure like colonoscopy.

• Key modifiable risk factors include obesity, physical inactivity, a diet high in red and processed meats, smoking, and heavy alcohol use, while non-modifiable risks include age over 50, personal or family history, inflammatory bowel disease, and certain genetic syndromes such as Lynch.

• Lynch syndrome can raise lifetime colon cancer risk up to about 80%, and increases risk for other cancers; when more than one close relative is affected, genetic testing and targeted surveillance are often advised for family members.

• Screening is recommended from ages 45–75 for average-risk individuals, with methods ranging from stool-based tests to colonoscopy; colonoscopy plays a dual role in detection and removal of polyps, reducing cancer risk and enabling biopsy for diagnosis.

• Treatment typically involves surgery to remove affected colon or rectal tissue, possibly followed by colostomy; radiation is more commonly used for rectal cancer, and systemic therapies—chemotherapy, targeted therapy, and immunotherapy—are employed based on stage and tumor biology to shrink disease, eradicate remaining cancer cells, or manage spread.